The Allstate Corporation $ALL Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB decreased its holdings in shares of The Allstate Corporation (NYSE:ALL) by 25.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 52,804 shares of the insurance provider’s stock after selling 17,617 shares during the quarter. Handelsbanken Fonder AB’s holdings in Allstate were worth $12,564,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Allied Private Wealth LLC purchased a new stake in Allstate during the 2nd quarter valued at about $29,000. MV Capital Management Inc. purchased a new position in Allstate in the 4th quarter worth approximately $25,000. Navalign LLC acquired a new position in shares of Allstate during the 4th quarter worth approximately $27,000. Evolution Wealth Management Inc. grew its position in shares of Allstate by 7,000.0% in the first quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider’s stock valued at $29,000 after purchasing an additional 140 shares in the last quarter. Finally, Palisade Asset Management LLC purchased a new stake in shares of Allstate in the third quarter valued at approximately $31,000. 76.47% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Allstate

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Allstate opened a new claims-training campus in Dallas. The 33,000-square-foot Allstate Claims University will train the company’s 23,000 claims professionals, who handle approximately 8.5 million claims annually. Management says the investment should improve damage assessment and customer service, potentially supporting operating efficiency and claims quality. Allstate Claims University announcement
• Positive Sentiment: Analyst expectations remain supportive. JPMorgan reportedly expects further appreciation in Allstate’s stock, while Dowling & Partners raised its FY2026 EPS estimate to $35.50 from $30.50 and its FY2027 estimate to $25.50 from $24.00. The revisions reinforce optimism following Allstate’s recent earnings beat, although some longer-term estimates remain below near-term expectations. JPMorgan Allstate price outlook
• Neutral Sentiment: Allstate’s broader AI and employee-development initiatives are receiving attention. These efforts could improve productivity and customer service over time, but their effect on earnings is not yet quantifiable. Allstate AI and mentorship article
• Negative Sentiment: An Ontario court rejected Allstate’s challenge involving excluded-driver coverage. The decision represents an adverse legal outcome in Canada and could limit Allstate’s position in the coverage dispute, though the immediate financial impact was not disclosed. Ontario excluded-driver coverage court ruling
• Negative Sentiment: Two Allstate insiders sold sizable positions. COO Mario Rizzo sold 56,225 shares for approximately $14.9 million, reducing his holdings by 40.6%. John Dugenske separately sold 32,996 shares worth about $8.9 million, cutting his position by 71.7%. Although insider sales may reflect personal financial planning, their size can weigh on investor sentiment. Allstate insider transactions

Insider Activity at Allstate

In other news, COO Mario Rizzo sold 56,225 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $264.48, for a total value of $14,870,388.00. Following the sale, the chief operating officer directly owned 82,227 shares of the company’s stock, valued at approximately $21,747,396.96. The trade was a 40.61% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Andrea Redmond sold 2,225 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $202.91, for a total transaction of $451,474.75. Following the transaction, the director directly owned 2,225 shares of the company’s stock, valued at $451,474.75. The trade was a 50.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 92,996 shares of company stock valued at $24,543,894 in the last ninety days. Insiders own 1.55% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on ALL shares. Citigroup downgraded Allstate from a “neutral” rating to a “sell” rating and lifted their price objective for the stock from $226.00 to $240.00 in a research report on Tuesday. Weiss Ratings raised Allstate from a “buy (a-)” rating to a “buy (a)” rating in a research note on Thursday, August 6th. UBS Group lifted their price target on Allstate from $261.00 to $275.00 and gave the stock a “neutral” rating in a report on Monday. Morgan Stanley set a $265.00 price target on shares of Allstate in a research report on Tuesday. Finally, JPMorgan Chase & Co. upped their price objective on shares of Allstate from $282.00 to $292.00 and gave the company an “overweight” rating in a report on Tuesday. Three investment analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, ten have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, Allstate presently has a consensus rating of “Hold” and an average price target of $265.53.

Allstate Price Performance

NYSE:ALL opened at $260.94 on Friday. The Allstate Corporation has a 52 week low of $188.08 and a 52 week high of $277.22. The stock’s fifty day moving average is $245.71 and its two-hundred day moving average is $222.56. The company has a market capitalization of $65.98 billion, a P/E ratio of 5.21, a P/E/G ratio of 0.40 and a beta of 0.16. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.24.

Allstate (NYSE:ALL) last issued its quarterly earnings data on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.06 by $2.93. The firm had revenue of $15.43 billion during the quarter, compared to the consensus estimate of $15.46 billion. Allstate had a return on equity of 41.64% and a net margin of 18.97%.The company’s quarterly revenue was up 11.8% on a year-over-year basis. During the same period last year, the company earned $5.94 EPS. Equities analysts expect that The Allstate Corporation will post 33.92 EPS for the current year.

Allstate Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Monday, August 31st will be given a dividend of $1.08 per share. The ex-dividend date is Monday, August 31st. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.7%. Allstate’s dividend payout ratio (DPR) is currently 8.63%.

Allstate Profile

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.